{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:15:28Z","timestamp":1793438128287,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.clindermatol.2016.05.012","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T09:03:57Z","timestamp":1463907837000},"page":"614-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Phototherapy for sclerosing skin conditions"],"prefix":"10.1016","volume":"34","author":[{"given":"Noelle M.","family":"Teske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi T.","family":"Jacobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2016.05.012_bb0005","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1073\/pnas.90.14.6666","article-title":"Wavelengths effective in induction of malignant melanoma","volume":"90","author":"Setlow","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0010","series-title":"Photodermatology","first-page":"25","article-title":"The molecular and genetic effects of ultraviolent radiation exposure on skin","author":"Young","year":"1999"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-5945-4-11","article-title":"UVA\/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review","volume":"4","author":"Breuckmann","year":"2004","journal-title":"BMC Dermatol"},{"issue":"Suppl. 3","key":"10.1016\/j.clindermatol.2016.05.012_bb0020","first-page":"iii52","article-title":"Phototherapy: a promising treatment option for skin sclerosis in scleroderma?","volume":"45","author":"Sunderkotter","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/medicina46100092","article-title":"Pathogenesis and treatment modalities of localized scleroderma","volume":"46","author":"Valanciene","year":"2010","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0781.2005.00154.x","article-title":"Phototherapy and photochemotherapy of sclerosing skin diseases","volume":"21","author":"Brenner","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0040","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(05)62472-5","article-title":"Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts","volume":"350","author":"Gruss","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0045","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1751-1097.1994.tb02982.x","article-title":"UVA-induced autocrine stimulation of fibroblast-derived collagenase\/MMP-1 by interrelated loops of interleukin-1 and interleukin-6","volume":"59","author":"Wlaschek","year":"1994","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0050","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1073\/pnas.030528897","article-title":"Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin","volume":"97","author":"Stege","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1523-1747.2002.01834.x","article-title":"Ultraviolet irradiation alters transforming growth factor beta\/smad pathway in human skin in vivo","volume":"119","author":"Quan","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2008.07.042","article-title":"Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review","volume":"59","author":"Kroft","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00403-006-0695-8","article-title":"Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma","volume":"298","author":"Kreuter","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1139\/o82-064","article-title":"Photolysis of pyridinoline, a cross-linking amino acid of collagen, by ultraviolet light","volume":"60","author":"Sakura","year":"1982","journal-title":"Can J Biochem"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0781.2004.00080.x","article-title":"Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study","volume":"20","author":"El-Mofty","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1747.1999.00474.x","article-title":"UVA1 radiation triggers two different final apoptotic pathways","volume":"112","author":"Godar","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0085","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.186.10.1763","article-title":"Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy","volume":"186","author":"Morita","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s004030100216","article-title":"Opposing effects of UVA1 phototherapy on the expression of bcl-2 and p53 in atopic dermatitis","volume":"293","author":"Breuckmann","year":"2001","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0095","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1365-2133.1998.02063.x","article-title":"Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin","volume":"138","author":"Skov","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.0022-202X.2005.23615.x","article-title":"B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity","volume":"124","author":"Byrne","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00403-004-0513-0","article-title":"Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis","volume":"296","author":"Breuckmann","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s001050050119","article-title":"PUVA bath therapy. Indications and practical implementation","volume":"45","author":"Kerscher","year":"1994","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0115","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(95)91843-4","article-title":"Treatment of localised scleroderma by UVA1 phototherapy","volume":"346","author":"Kerscher","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0120","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(97)80277-0","article-title":"High-dose UVA1 radiation therapy for localized scleroderma","volume":"36","author":"Stege","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","article-title":"Low-dose UVA phototherapy for treatment of localized scleroderma","volume":"38","author":"Kerscher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1067\/mjd.2001.117735","article-title":"Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells","volume":"45","author":"Camacho","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","article-title":"Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea","volume":"18","author":"Kreuter","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000073093","article-title":"Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method","volume":"207","author":"de Rie","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea: part II. Outcome measures and treatment","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2133.1997.tb14925.x","article-title":"Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood","volume":"136","author":"Gruss","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0155","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2008.12.013","article-title":"Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment","volume":"60","author":"Sator","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0781.2006.00245.x","article-title":"UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States","volume":"22","author":"Tuchinda","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.2009.09438.x","article-title":"Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study","volume":"162","author":"Andres","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0781.2000.d01-1.x","article-title":"Low-dose broad-band UVA in morphea using a new method for evaluation","volume":"16","author":"El-Mofty","year":"2000","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0175","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1996.03890350014001","article-title":"PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients","volume":"132","author":"Kerscher","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0180","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2230.2008.02890.x","article-title":"Photochemotherapy for localized morphoea: effect on clinical and molecular markers","volume":"33","author":"Usmani","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1440-0960.2010.00701.x","article-title":"Narrowband UVB phototherapy in children: a New Zealand experience","volume":"51","author":"Tan","year":"2010","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0190","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaad.2003.08.026","article-title":"Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis","volume":"50","author":"Kreuter","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/archderm.136.2.275","article-title":"Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy","volume":"136","author":"von Kobyletzki","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0200","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1067\/mjd.2000.105165","article-title":"Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis","volume":"43","author":"Morita","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-0781.2007.00308.x","article-title":"Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis","volume":"23","author":"Durand","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0781.2009.00422.x","article-title":"Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis","volume":"25","author":"Rose","year":"2009","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0781.2011.00570.x","article-title":"Successful treatment of microstomia with UVA1 phototherapy in systemic sclerosis","volume":"27","author":"Tewari","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archderm.135.5.603","article-title":"Oral psoralen-UV-A for systemic scleroderma","volume":"135","author":"Hofer","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1346-8138.1996.tb04054.x","article-title":"Successful treatment of scleroderma with PUVA therapy","volume":"23","author":"Kanekura","year":"1996","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0230","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archderm.1997.03890480123023","article-title":"Psoralen bath plus UV-A therapy. Possibilities and limitations","volume":"133","author":"Luftl","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0235","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2230.2009.03660.x","article-title":"Photochemotherapy for systemic sclerosis: effect on clinical and molecular markers","volume":"35","author":"Usmani","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/art.22289","article-title":"Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192","volume":"56","author":"Denton","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mjd.2002.118552","article-title":"Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study","volume":"46","author":"Kreuter","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0250","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2230.2006.02082.x","article-title":"UVA1 phototherapy for genital lichen sclerosus","volume":"31","author":"Beattie","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000065858","article-title":"Treatment of genito-anal lesions in inflammatory skin diseases with PUVA cream photochemotherapy: an open pilot study in 12 patients","volume":"205","author":"Reichrath","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0260","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jaad.2005.08.017","article-title":"Psoralen-UVA treatment for generalized prepubertal extragenital lichen sclerosus et atrophicus","volume":"55","author":"Dalmau","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0781.2008.00328.x","article-title":"Efficacy of UVA1 phototherapy in 230 patients with various skin diseases","volume":"24","author":"Rombold","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archderm.143.1.19","article-title":"Progressive extragenital lichen sclerosus successfully treated with narrowband UV-B phototherapy","volume":"143","author":"Colbert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00128071-200809030-00006","article-title":"Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA","volume":"9","author":"Valdivielso-Ramos","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0280","first-page":"1061","article-title":"Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA)","volume":"17","author":"Vogelsang","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0285","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bmt.1701460","article-title":"Chronic graft-versus-host disease treated with UVB phototherapy","volume":"22","author":"Enk","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0290","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0781.2002.00719.x","article-title":"Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease","volume":"18","author":"Leiter","year":"2002","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0295","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1067\/mjd.2002.121352","article-title":"UVA1 therapy for sclerodermic graft-versus-host disease of the skin","volume":"46","author":"Stander","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0300","first-page":"1169","article-title":"Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease","volume":"88","author":"Calzavara Pinton","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0305","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.bmt.1704804","article-title":"Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin","volume":"35","author":"Wetzig","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0310","first-page":"1027","article-title":"Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy","volume":"8","author":"Hoffner","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0315","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0190-9622(00)90023-9","article-title":"Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy","volume":"42","author":"Grundmann-Kollmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0320","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaad.2004.02.011","article-title":"Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life","volume":"51","author":"Ziemer","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0325","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archdermatol.2009.245","article-title":"UV-A1 therapy for nephrogenic systemic fibrosis","volume":"145","author":"Tran","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0330","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archderm.140.11.1322","article-title":"UV-A1 phototherapy improves nephrogenic fibrosing dermopathy","volume":"140","author":"Kafi","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0335","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jaad.2007.08.035","article-title":"Treatment of nephrogenic systemic fibrosis with Re-PUVA","volume":"59","author":"Duffy","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0340","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaad.2008.12.031","article-title":"Treatments for psoriasis and the risk of malignancy","volume":"60","author":"Patel","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0345","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archderm.141.12.1549","article-title":"Dose-response and time-course characteristics of UV-A1 erythema","volume":"141","author":"Beattie","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0350","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1468-3083.2007.02576.x","article-title":"Period of remission after treatment with UVA-1 in sclerodermic skin diseases","volume":"22","author":"Kroft","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0355","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000051588","article-title":"Bullous pemphigoid in a patient treated with UVA-1 phototherapy for disseminated morphea","volume":"202","author":"Sacher","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0360","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0781.2010.00529.x","article-title":"Merkel cell carcinoma arising in immunosuppressed patients treated with high-dose ultraviolet A1 (320-400 nm) phototherapy: a report of two cases","volume":"26","author":"Calzavara-Pinton","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0365","first-page":"705","article-title":"Association between UVA1 and PUVA bath therapy and development of malignant melanoma","volume":"52","author":"Wallenfang","year":"2001","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0370","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study","volume":"336","author":"Stern","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0375","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2133.2008.08776.x","article-title":"Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy","volume":"159","author":"Hearn","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.05.012_bb0380","series-title":"Guide to clinical preventive services: report of the U.S. Preventive Services Task Force","first-page":"24","author":"US Preventive Services Task Force","year":"1989"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16301481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16301481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T10:32:26Z","timestamp":1567938746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X16301481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0738081X16301481"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.05.012","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phototherapy for sclerosing skin conditions","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}